CRISPR Therapeutics and Sirius Therapeutics Partner to Advance Long-Acting siRNA Therapy for Thromboembolic Disorders

Collaboration brings together complementary capabilities to co-develop and co-commercialize SRSD107, a next generation, long-acting Factor XI (FXI) small...

May 20, 2025 | Tuesday | News
WuXi Biologics and CANbridge Launch China’s First Locally Developed Enzyme Replacement Therapy for Gaucher Disease

Enabled by WuXi Biologics' industry-leading integrated technology platform, velaglucerase-beta for injection has successfully advanced from concept to ...

May 19, 2025 | Monday | News
Shanghai Ark Biopharma Reports Positive Phase II Results for AK3280 in IPF Patients Signaling New Hope in Fibrotic Lung Disease Treatment

Shanghai Ark Biopharmaceutical announced positive top-line Phase II study results for its novel anti-fibrotic drug AK3280 in treatment of idiopathic...

May 16, 2025 | Friday | News
AAFA Raises Alarm on MFN Drug Pricing Policy, Cites Risk to Patient Access

The Asthma and Allergy Foundation of America (AAFA) appreciates the President’s Executive Order calling attention to America’s persistent pro...

May 16, 2025 | Friday | News
Silo Pharma Engages Veloxity Labs to Advance IND-Enabling Study for PTSD Treatment Candidate SPC-15

Silo Pharma, Inc., a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems,  announced that it has e...

May 15, 2025 | Thursday | News
Exelixis Advances Invenra-Discovered XB628 into Phase 1 Clinical Trial for Solid Tumors

Invenra Inc., a biotechnology company specializing in the discovery and development of multispecific antibodies,  announced that its collaboration par...

May 14, 2025 | Wednesday | News
QIAGEN Acquires Genoox for $70M to Expand AI-Powered Genomic Interpretation Portfolio

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insigh...

May 13, 2025 | Tuesday | News
Eurofins Viracor Launches BAL Specimen Testing for NeXGen® Fungal/AFB NGS Assay to Transform Respiratory Infection Diagnostics

Eurofins Viracor, a leading specialty diagnostics laboratory, is proud to announce a groundbreaking advancement in respiratory infection diagnostics with...

May 08, 2025 | Thursday | News
Aspen Neuroscience Reports Positive 6-Month Data for ANPD001 in Parkinson’s Disease Ahead of IAPRD 2025 Presentation

ANPD001 was well tolerated with no major safety issues in low-dose cohort Patients showed early improvements in patient-reported and clinician-re...

May 08, 2025 | Thursday | News
Theriva Biologics Reports Positive Phase 2b Data for VCN-01 in Metastatic Pancreatic Cancer

- Patients treated with VCN-01 (zabilugene almadenorepvec) plus standard gemcitabine/nab-paclitaxel chemotherapy had increased overall survival, progress...

May 08, 2025 | Thursday | Reports
BioAegis Launches Global 600-Patient Phase 2 Trial of rhu-pGSN to Treat ARDS and Advance Inflammation-Modulating Therapies

600-patient study to assess efficacy of rhu-pGSN, an immune system regulator that interrupts the NLRP3 inflammasome and boosts macrophage clearance of pa...

May 07, 2025 | Wednesday | News
Hovione and Firstgene Partner to Advance Precision Gene Therapy for Liver Cancer Using Novel AAV-Like Vector Platform

Exclusive licensing and R&D collaboration accelerate the development of a novel gene vector platform for precision gene therapy in Hepatocellular Car...

May 07, 2025 | Wednesday | News
Australia’s Immutep Achieves 17.6-Month Survival with Chemo-Free Immunotherapy in Head and Neck Cancer

Complementary nature of these two immunotherapies leads to excellent 17.6-month median Overall Survival in head and neck cancer patients with PD-L1 CPS...

May 06, 2025 | Tuesday | News
Can-Fite Secures $175M to Advance Oral A3AR Therapies into Phase III for Liver Cancer and Psoriasis

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases, toda...

May 06, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close